SARTORIUS STEDIM BIOTECH SA 05/04/2016 AGM
E.1Approve MergerOppose
E.2Approve potential reduction of the Company 's capitalFor
E.3Recording of implementation of the merger For
E.4Approve Share SplitFor
E.5To authorise capital increase by transfer of reservesFor
E.6Amend Articles: Article 5 of Section 1For
E.7Global authorisation to issue with pre-emptive subscription right shares or other securities giving way to new capitalFor
E.8Issue Shares for CashOppose
E.9Approve Issue of Shares for Private PlacementOppose
E.10Approve Adoption of Anti-takeover Measure (poison pill)Oppose
E.11Approve Issue of Shares for Contribution in KindFor
E.12Delegation of authority granted to the Board of Directors to decide upon increasing the Company capital through incorporation of reserves, benefits or premiums on issuesFor
E.13Approve Issue of Shares for Employee Saving PlanOppose
E.14Authorise Cancellation of Treasury SharesFor
O.15Approve Financial Statements and Discharge the BoardFor
O.16Approve Financial StatementsFor
O.17Approve the DividendFor
O.18Report of the president of the Board of Directors covered by the Article L. 225-37 of the French commercial code. For
O.19Setting the annual amount of attendance fees to be allocated to members of the Board of Directors Oppose
O.20Approve Fees Payable to Joachim Kreuzburg, CEO and ChairmanOppose
O.21Approve Fees Payable to Reinhard Vogt, Vice-CEOOppose
O.22Approve Fees Payable to Volker Niebel, Vice-CEOOppose
O.23Approve Fees Payable to Oscar-Werner Reif, Vice-CEOOppose
O.24Re-elect Joachim Kreuzburg Oppose
O.25Re-elect Volker Niebel For
O.26Re-elect Reinhard VogtFor
O.27Re-elect Arnold PicotOppose
O.28Re-elect Bernard Lemaitre Oppose
O.29Re-elect Liliane De LassusFor
O.30Re-elect Henri RieyFor
O.31Authorise the Board of Directors to allow the Company to intervene in relation to its own shares For
O.32Powers to carry out all legal formalitiesFor